Phillip M Schneider

Title: The Innovations of Phillip M Schneider

Introduction

Phillip M Schneider is a notable inventor based in Alameda, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of fibronectin and antihemophilic factor isolation. With a total of 2 patents, Schneider's work has had a meaningful impact on medical research and treatment.

Latest Patents

Schneider's latest patents include innovative methods for isolating fibronectin compositions from blood plasma. One patent focuses on novel compositions containing fibronectin and methods of isolating these compositions and fibronectin itself from blood plasma. The second patent details methods for preparing fibronectin and antihemophilic factor in commercial quantities from blood plasma. In these methods, a blood plasma fraction containing both fibronectin and antihemophilic factor is isolated and solubilized in an aqueous medium. The solution is then acidified and chilled to form an acid-chill precipitate, which contains a major proportion of the fibronectin, while the solution retains a major proportion of the antihemophilic factor. This innovative approach allows for the effective isolation of both components.

Career Highlights

Phillip M Schneider has been associated with Cutter Laboratories, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of fibronectin in medical treatments.

Collaborations

Some of Schneider's notable coworkers include Donald G Wallace and John L Lundblad. Their collaborative efforts have further enhanced the research and development of biopharmaceuticals.

Conclusion

Phillip M Schneider's contributions to the field of biochemistry through his patents and collaborations have paved the way for advancements in medical treatments. His innovative methods for isolating fibronectin and antihemophilic factor continue to influence research in this vital area.